Emami board approves demerger of realty business

2009 June 22

tags: 506720, Emami-board, Zandu Pharma, ZANDUPHARM

by Bhaskar

Emami board approves demerger of realty business; approves demerger of FMCG business of Zandu into the company. The company offers 14 shares in the company for every share held in Zandu.

Zandu Pharma
BSE: 506720 NSE: ZANDUPHARM
Industry: Pharmaceuticals

BSE Group : B2     Last Price
BSE 19-Jun     Rs.7476.50
NSE 19-Jun     Rs.7499.80

Your Ad Here

No related posts.

Comments are closed for this entry.

This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 2.5 India License

Vigilance Theme by Jestro

DISCLAIMER : Stock trading involves high risk and one can lose Substantial amount of money.The recommendations made herein Do not constitute an offer to sell or solicitation to buy any of the Securities mentioned. No representations can be made that recommendations contained herein will be profitable or they will Not result in losses. Readers using the information contained herein are solely responsible for their actions. The information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on technical analysis only.

News about Indian Stock Markets

Emami board approves demerger of realty business

Recent Posts

Categories

Archives

Search

Authors

What I'm Doing...